title: Continuous glucose monitoring in type 1 diabetes.
abstract: Continuous glucose monitoring is becoming increasingly more widespread for the routine care of people with type 1 diabetes mellitus and may eventually be used in closed-loop artificial beta-cell systems. The current "state of the art" of this technology, including accuracy, performance in clinical trials, limitations, and recommendations for use, is discussed for the two currently approved continuous glucose monitoring devices.
authors.affiliation: Yale University School of Medicine, Department of Pediatrics, PO Box 208064, 333 Cedar Street, New Haven, CT 06520, USA. stuart.weinzimer@yale.edu
authors.forename: Stuart A
authors.initials: SA
authors.lastname: Weinzimer
authors.forename: William V
authors.initials: WV
authors.lastname: Tamborlane
authors.forename: H Peter
authors.initials: HP
authors.lastname: Chase
authors.forename: Satish K
authors.initials: SK
authors.lastname: Garg
mesh_terms: D001786:Blood Glucose / Q000032:analysis; D015190:Blood Glucose Self-Monitoring / Q000191:economics / Q000295:instrumentation / Q000379:methods*; D003922:Diabetes Mellitus, Type 1 / Q000097:blood*; D005502:Food; D006801:Humans; D007003:Hypoglycemia / Q000175:diagnosis; D007328:Insulin / Q000008:administration & dosage; D012680:Sensitivity and Specificity
chemical_list: D001786:Blood Glucose; D007328:Insulin